Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Zuckerman, Arie J.
1990.
Vaccines against hepatitis A and B.
Baillière's Clinical Gastroenterology,
Vol. 4,
Issue. 3,
p.
775.
Higgins, Gillian
Wreghitt, T.G.
Gray, J.J.
Blagdon, J.
and
Taylor, C.E.D.
1990.
Hepatitis A virus antibody in East Anglian blood donors.
The Lancet,
Vol. 336,
Issue. 8726,
p.
1330.
Heap, B J
1991.
Notification of communicable diseases..
BMJ,
Vol. 303,
Issue. 6808,
p.
991.
Cook, L.
1991.
Guidelines for doctors with HIV infection.
BMJ,
Vol. 303,
Issue. 6808,
p.
990.
Masterton, R.G.
Strike, P.W.
and
Tettmar, R.E.
1991.
Hepatitis A immunity and travel history.
Journal of Infection,
Vol. 23,
Issue. 3,
p.
321.
Zuckerman, A J
1991.
Notification of viral hepatitis..
BMJ,
Vol. 303,
Issue. 6808,
p.
991.
Turner, P.C
Eglin, R.E
Woodward, C.G
and
Dave, J
1992.
Screening before hepatitis A vaccination.
The Lancet,
Vol. 340,
Issue. 8828,
p.
1160.
Steffen, R.
1993.
Hepatitis A and hepatitis B: Risks compared with other vaccine preventable diseases and immunization recommendations.
Vaccine,
Vol. 11,
Issue. 5,
p.
518.
Howell, D. R.
Thompson, C. J.
and
Barbara, J. A. J.
1993.
Anti‐HAV prevalence in a U.K. urban blood donor population and the effect on human normal Ig provision.
Transfusion Medicine,
Vol. 3,
Issue. 4,
p.
285.
Behrens, R.H.
and
Doherty, J.F.
1993.
Severe hepatitis A despite passive immunisation.
The Lancet,
Vol. 341,
Issue. 8850,
p.
972.
Studer, S.
Joller-Jemelka, H. I.
Steffen, R.
and
Grob, P. J.
1993.
Prevalence of hepatitis a antibodies in Swiss travellers.
European Journal of Epidemiology,
Vol. 9,
Issue. 1,
p.
50.
Cumberland, N S
Masterton, R G
Green, A D
and
Sims, M M
1994.
Prevalence of Immunity to Hepatitis A in Recruits to the British Army and Royal Air Force.
Journal of the Royal Army Medical Corps,
Vol. 140,
Issue. 2,
p.
71.
Zuckerman, Jane N.
and
Powell, Lee
1994.
Hepatitis A antibodies in attenders of London travel clinics: Cost‐benefit of screening prior to hepatitis A immunisation.
Journal of Medical Virology,
Vol. 44,
Issue. 4,
p.
393.
Garin, Daniel
Vidor, Emmanuel
Wallon, Martine
Fanget, Bernard
Brasseur, Philippe
Delolme, Henri
Caron, François
Mojon, Madeleine
Gravey, Alain
Humbert, Guy
Flehmig, Bertram
and
Peyron, François
1995.
Good immunogenicity of GBM strain inactivated hepatitis A vaccine in healthy male adults.
Vaccine,
Vol. 13,
Issue. 2,
p.
220.
Arístegui, J.
Garrote, E.
Morales, J. L.
Gallego, Maria S.
Dal-Ré, R.
and
González, A.
1995.
Safety and immunogenicity of an inactivated hepatitis A vaccine in children 2 to 5 years old.
Infection,
Vol. 23,
Issue. 5,
p.
334.
Ansdell, Vernon E.
and
Abou-Sayf, Frank
1996.
Prevalence of Hepatitis A Antibody in Travelers from Hawaii.
Journal of Travel Medicine,
Vol. 3,
Issue. 1,
p.
27.
Bernal, W.
Smith, H.M.
and
Williams, Roger
1996.
A community prevalence study of antibodies to hepatitis A and E in inner-city London.
Journal of Medical Virology,
Vol. 49,
Issue. 3,
p.
230.
Carrillo-Santisteve, Paloma
Tavoschi, Lara
Severi, Ettore
Bonfigli, Sandro
Edelstein, Michael
Byström, Emma
Lopalco, Pierluigi
Alfonsi, Valeria
Chilbek, Roman
Dominguez, Angela
Galanakis, Emmanouil
Janta, Denisa
Kojouharova, Mira
Ott, Jördis J
Nelson, Noele
Papaevangelou, Vassiliki
Shouval, Daniel
Uhnoo, Ingrid
and
Usonis, Vytautas
2017.
Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review.
The Lancet Infectious Diseases,
Vol. 17,
Issue. 10,
p.
e306.